Health Care: Drugs

AMAG Pharmaceuticals Inc (AMAG: NASDAQ)

$68.92 1.78 | 2.65%
06/30/15 - 02:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 124.38M 80.86M 85.38M 61.25M
Cost of Sales 4.37M 6.12M 8.33M 4.36M
Gross Operating Profit 120.01M 74.74M 77.05M 56.89M
Selling, General, and Administrative Expenses 72.25M 59.95M 53.07M 68.86M
Research & Development 24.16M 20.56M 33.30M 58.14M
Operating Income before D & A (EBITDA) 23.60M -5.77M -9.32M -70.11M
Depreciation & Amortization 15.93M 5.84M 5.89M 6.18M
Interest Income 975.00K 1.05M 1.29M 1.75M
Other Income - Net -9.26M 964.00K -1.47M -193.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -2.64M -9.60M -17.60M -78.24M
Interest Expense 14.70M 0.00 0.00 0.00
Pre-Tax Income -17.34M -9.60M -17.60M -78.24M
Income Taxes -153.16M 0.00 -854.00K -1.17M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 135.82M -9.60M -16.75M -77.07M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 135.82M -9.60M -16.75M -77.07M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 135.82M -9.60M -16.75M -77.07M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
137.84M -9.60M -14.54M -73.56M
Preferred Dividends
Net Income Available To Common 135.82M -9.60M -16.75M -77.07M
Basic EPS from Continuing Ops. 6.06 -0.44 -0.78 -3.64
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 6.06 -0.44 -0.78 -3.64
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 6.06 -0.44 -0.78 -3.64
Basic Normalized Net Income/Share 6.15 -0.44 -0.68 -3.47
EPS fr Continuing Ops. 5.38 -0.44 -0.78 -3.64
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 5.38 -0.44 -0.78 -3.64
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.07 0.00 0.00 0.00
EPS, Total 5.45 -0.44 -0.78 -3.64
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
5.46 -0.44 -0.68 -3.47
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with AMAG

Latest AMAG Headlines from TheStreet

More Financial News for AMAG

Press Releases for AMAG

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter